Alterity Therapeutics (PRNAD) Total Liabilities (2009 - 2025)

Alterity Therapeutics (PRNAD) has reported Total Liabilities for 16 consecutive years, with $1.7 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Total Liabilities fell 3.6% year-over-year to $1.7 million; the TTM figure through Dec 2025 stood at $1.7 million (down 3.6% YoY), while the FY2025 annual figure was $2.3 million, down 35.1% from the prior year.
• Total Liabilities came in at $1.7 million for Q4 2025 at Alterity Therapeutics, down from $2.3 million in the prior quarter.
• The five-year high for Total Liabilities was $4.2 million in Q2 2022, with the low at -$6.3 million in Q2 2024.
• Average Total Liabilities over 5 years is $1.5 million, with a median of $2.4 million recorded in 2021.
• Across the five-year window, Total Liabilities sank 13981.18% in 2024 and soared 137.11% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $2.8 million in 2021, then rose by 25.23% to $3.5 million in 2022, then dropped by 14.24% to $3.0 million in 2023, then slumped by 39.3% to $1.8 million in 2024, then declined by 3.6% to $1.7 million in 2025.
• According to Business Quant data, Total Liabilities over the past three periods registered $1.7 million, $2.3 million, and $1.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.